Target intelligence / Profile preview

Nitrous-oxide reductase (N2OR)

Target
N2OR
Molecular classification
Enzyme, Oxidoreductase, Metalloenzyme, Multicopper enzyme
01

Overview

Nitrous-oxide reductase (N2OR) is a **bacterial metalloenzyme** that catalyzes the final step of denitrification, reducing the potent greenhouse gas **nitrous oxide (N₂O) to inert dinitrogen (N₂)**[1][2][3][4][5]. It is a homodimeric multicopper oxidoreductase located in the periplasm of denitrifying bacteria, with each monomer containing two specialized copper centers: **CuA** (electron transfer site) and **CuZ** (catalytic site; a distinct tetranuclear copper-sulfide cluster)[2][4][5]. Head-to-tail dimerization positions these centers from opposing monomers in optimal proximity for cooperative catalysis[2][4][5]. N2OR is essential for environmental nitrogen cycling and mitigation of greenhouse gas emissions, as it is presently the only known enzyme capable of deleting N₂O from the biosphere[3][4][5]. Its activity is regulated by the *nosZ* gene, and its dysfunction or inhibition (by compounds including acetylene, azide, and cyanide) results in incomplete denitrification and heightened N₂O emissions[1][2][3]. N2OR does not have direct clinical applications or recognized roles in human disease but is a crucial environmental target in efforts to reduce atmospheric N₂O and its associated climate impacts.

Other names
Nitrogen:acceptor oxidoreductase (N₂O-forming)NosZNitrous oxide reductaseN₂O reductase
02

Mechanism of action

Inhibitors: Blockage of copper centers and/or active/catalytic sites, preventing electron transfer and subsequent reduction of N₂O to N₂[1]. - Enzymatic catalysis: 2H⁺/2e⁻-dependent reduction of N₂O to N₂ (biotransformation)[2][5].

03

Biological functions

Reduction of nitrous oxide (N₂O) to dinitrogen (N₂)Final step in bacterial denitrificationDetoxification of greenhouse gas N₂O
04

Disease associations

Other (no direct association with human disease; environmental relevance as main enzyme in N₂O removal during microbial denitrification)
05

Safety considerations

Null (not a therapeutic target in humans; no direct safety risks reported—main risks concern environmental context such as loss of N₂O mitigation in soil/microbiome)
06

Interacting drugs

Acetylene (inhibitor)

5 more in the full profile.

07

Biomarkers

Null (not applicable for patient selection or human clinical monitoring)

Beyond the preview

Go deeper on Nitrous-oxide reductase (N2OR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nitrous-oxide reductase (N2OR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call